Ning Shan

Dr. Ning Shan


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2019 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
RSRui-Jie Sun
Rui-Jie Sun
NSNing Shan
Ning Shan
Immune thrombocytopenic purpura (ITP) is a multifactorial autoimmune disease characterized by both increased platelet destruction and/or reduced platelet production. Even though they are detected in ≤ 50% of ITP patients, auto-antibodies play a pivotal role in the pathogenesis of ITP. Recent experimental and clinical observations have revealed abnormal autophagy in ITP patients. Autophagy is a catabolic process responsible for the elimination and recycling of cytoplasmic constituents, such as organelles and macromolecules, in eukaryotic cells. Additionally, it triggers cell death or promotes cell survival following various forms of stress, and maintains the microenvironment and stemness of haematopoietic stem cells. The role of autophagy in megakaryopoiesis, thrombopoiesis, and platelet function is slowly being uncovered. The abnormal autophagy in ITP patients may be caused by deletion of autophagy-related genes such as ATG7 and abnormal signalling due to overexpression of mTOR. These changes are thought to affect markers of haematopoietic stem cells, such as CD41 and CD61, and differentiation of megakaryocytes, ultimately decreasing the function and quantity of platelets and leading to the onset of ITP. This review highlights recent evidence on the essential role played by autophagy in megakaryopoiesis, megakaryocyte differentiation, thrombopoiesis, and platelet production. It also discusses the potential of targeting the autophagy pathway as a novel therapeutic approach against ITP.

1 April 2016 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
NSNing Shan
Ning Shan
LDLi-Li Dong
Li-Li Dong
XZXiao-Mei Zhang
Xiao-Mei Zhang
XLXin Liu
Xin Liu
YLYing Li
Ying Li

23 December 2020 in Journal of International Medical Research
Verified
Journal Article
Open access
PDF file
JZJing-Jing Zhu
Jing-Jing Zhu
NSNing Shan
Ning Shan
Considerable attention has been paid to interleukin (IL)-35 because of its immunosuppressive effects in a variety of autoimmune diseases. IL-35, a recently identified cytokine of the IL-12 family, is a negative regulatory factor secreted by IL-35-inducible regulatory T cells (iTr35 cells) and the recently reported regulatory B cells (Breg cells). Four biological effects of IL-35 have been discovered in vitro and in vivo: (i) suppression of T cell proliferation; (ii) conversion of naive T cells into iTr35 cells; (iii) downregulation of type 17 helper T (Th17) cells; and (iv) conversion of Breg cells into a Breg subset that produces IL-35 and IL-10. IL-35 plays an important role in a variety of autoimmune diseases, such as rheumatoid arthritis, allergic asthma and systemic lupus erythematosus. Primary immune thrombocytopaenia (ITP), which is characterized by isolated thrombocytopaenia and mild mucocutaneous to life-threatening bleeding, is an autoimmune disease with complex dysregulation of the immune system. Both antibody-mediated and/or T cell-mediated platelet destruction are key processes. In addition, impairment of T cells and cytokine imbalances have now been recognized to be important. This review summarizes the immunomodulatory effects of IL-35 and its role in the pathogenesis of ITP as mediated by T and B cells.

12 October 2020 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
SLShu-Yan Liu
Shu-Yan Liu
DYDai Yuan
Dai Yuan
RSRui-Jie Sun
Rui-Jie Sun
JZJing-Jing Zhu
Jing-Jing Zhu
NSNing Shan
Ning Shan

1 June 2020 in International Immunopharmacology
Verified
Journal Article
Closed access
SLShu-Yan Liu
Shu-Yan Liu
NSNing Shan
Ning Shan

14 November 2013 in Thrombosis Research
Verified
Journal Article
Closed access
PDF file
NSNing Shan
Ning Shan
YHYu Hu
Yu Hu
MHMing Hou
Ming Hou
JGJuan Gao
Juan Gao
XWXin Wang
Xin Wang
YLYing Li
Ying Li